VITT with inactivated SARS-CoV-2 vaccine - index case

We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of sym...

Full description

Saved in:
Bibliographic Details
Published in:Human vaccines & immunotherapeutics 2022-12, Vol.18 (1), p.2036556-2036556
Main Authors: Devi, Kanta, Ali, Natasha, Nasir, Nosheen, Mahmood, Syed Faisal
Format: Article
Language:English
Subjects:
Aged
Case Report
Coronavirus – Case Report
covid-19
COVID-19 - prevention & control
COVID-19 Vaccines - adverse effects
Humans
inactivated vaccine
Male
Purpura, Thrombocytopenic, Idiopathic
SARS-CoV-2
Thrombocytopenia - chemically induced
Vaccines - adverse effects
vitt
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.
ISSN:2164-5515
2164-554X
DOI:10.1080/21645515.2022.2036556